期刊文献+

蛋白激酶B参与门静脉高压症高动力循环的研究 被引量:1

Effect of AKT on splanchnic hyperdynamic circulation in portal hypertension
下载PDF
导出
摘要 目的探讨蛋白激酶B(AKT)与肝硬化门静脉高压症(portal hypertension,PHT)高动力循环的关系,特别是AKT与肝门静脉高压症内脏血管收缩反应性降低的关系。方法将SD大鼠随机分为4组:正常对照组(N组,n=7)、四氯化碳诱导的肝硬化门静脉高压组(PHT组,n=7),经AKT特异性阻滞剂LY294002处理的门静脉高压组(LY组,n=7)和注射二甲基亚枫(DMOS)的门静脉高压组(DMOS组,n=7),分别测量门静脉压力(portal vein pressure,pp),离体肠系膜分支动脉对缩血管物质去甲肾上腺素(norepinephrine,NE)的反应性,应用LY294002对离体微动脉收缩反应性的影响以及肠系膜动脉内皮细胞内AKT、内皮一氧化氮合酶(eNOS)的蛋白表达变化。结果①与N组相比,PHT组PP明显增高(P<0.01),应用LY294002后,PP无明显降低(P>0.05);②PHT组肠系膜微动脉对NE的反应性较N组明显降低(P<0.01),LY294002可改善这种低反应性(P<0.01);③AKT在PHT肠系膜动脉内皮中的表达明显上调(P<0.05),eNOS的表达PHT组和N组无明显差别(P>0.05),但p-eNOS的表达在PHT组动脉内皮中明显增高(P<0.05)。结论肝硬化门静脉高压症的内脏动脉中,AKT的表达上调,通过促进eNOS的活化和降低血管收缩反应性,参与内脏高动力循环的形成。 Objective To investigate the role of AKT in hyperdynamic circulation of PHT,and to analyze its effect on the contractility of splanchnic arteries and the possible mechanism.Methods All the rats involved in this experiment were divided into four groups,as normal rats (group N,n=7),CC14 induced portal hypertension rats (group PHT,n=7),rats with portal hypertension treated by LY294002 (group LY,n=8) and portal hypertensional rats treated by DMOS (group DMOS,n=7).The levels of portal vein pressure (PP) were tested respectively.Vascular reactivities of isolated mesenteric microcirculational arteries to norepinephrine (NE) were determined by a vessel perfusion system.The expressions of AKT and eNOS were detected with Western blotting.Results ① The pp of group PHT was apparently higher than that of the group N (P<0.01),LY294002 had little effects in reducing pp of PHT rats (P>0.05); ② Compared with group N,the contractility of group PHT to NE decreased obviously (P<0.01),LY294002 could partially attenuate this vasohyporesponsiveness (P<0.01); ③ There was no significant difference in levels of eNOS in both groups (P>0.05),but the protein levels of AKT and p-eNOS were highly upregulated in group PHT,compared with group N (P<0.05).Conclusion The excessive expression of AKT in mesenteric arteries may participate in development of splanchnic hyperdynamic of PHT,the possible mechanism may be invdving the activation of eNOS and impair of the contractility of mesentery artery to NE.
出处 《肝胆胰外科杂志》 CAS 2014年第3期226-229,共4页 Journal of Hepatopancreatobiliary Surgery
关键词 高血压 门静脉 高动力循环 蛋白激酶B 血管低反应性 大鼠 hypertension, portal vein hyperdynamic circulation AKT vasohyporesponsiveness rats
  • 相关文献

参考文献5

二级参考文献101

  • 1Hui Cao, Jia Xu, Rong Hua, Fang-Bin Meng, Jiang-Feng Qiu and Zhi-Yong Wu Department of Surgery, Renji Hospital, Shanghai Second Medical University, Shanghai 200127, China.Expression of cyclooxygenase in hyperdynamic portal hypertensive rats[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):252-256. 被引量:8
  • 2Kato T, Levi D, DeFaria W, et al. A new approach to the portal vein reconstruction in liver transplantation in patients with patent distal splenorenal shunts. XVIII international congress of the transplantation sociaty , 2000.
  • 3Woodle ES, Darcy M, White HM, et al. Intrahepatic portosystemic vascular stents: A bridge to hepatic transplantation. Surg, 1993,344-351.
  • 4Menegaux F, Keeffe EB, Baker E, et al. Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Arch Surg, 1994, 129:1018-1024.
  • 5Abouljoud MS, Levy MF, Rees CR, et al. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transpl, 1995, 59:226-229.
  • 6Lerut JP, Goffette P, MoUe G, et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eightpatients. Transpl, 1999, 68 : 379-384.
  • 7Yoshida EM, Lake JR. Selection of patients for liver transplantation in 1997 and beyond. Clinics in Liver Disease. 1997.1:247-261.
  • 8D'Amico G, Pailiarol, Bosch J. The treatment of portal hypertension: A meta-analytic review. Hepatol, 1995,22:332.
  • 9Ploeg Pal, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-A multivariate analysis.Transpl,1993, 55:807-813.
  • 10Chang FY, Singh N, Gayowski T, et al. Thromboeytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transpl, 2000, 69 : 70-75.

共引文献31

同被引文献16

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部